Latest News

Looking for older news? View News Archive >


Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina™ in the Treatment of Diabetic Macular Edema (DME)

Date: June 22, 2015 | READ MORE >

Ampio Pharmaceuticals Provides Information on the Formation and Significance of Aytu BioScience to Ampio Shareholders

Date: June 16, 2015 | READ MORE >

Ampio Pharmaceuticals Reports the Synergistic Effects of Ampion in the Treatment of Osteoarthritis of the Knee in Three Peer-reviewed Publications

Date: June 9, 2015 | READ MORE >

Ampio Pharmaceuticals Announces Update of STRIDE Study for the Investigation of Pain Associated with Osteoarthritis

Date: June 4, 2015 | READ MORE >

Ampio Pharmaceuticals Announces Positive Study Results on Optina for the Treatment of Diabetic Macular Edema

Date: May 21, 2015 | READ MORE >

Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. EST

Date: April 21, 2015 | READ MORE >

AMPIO Announces Ampion™ STRIDE Study Results

Date: April 20, 2015 | READ MORE >

Ampio Announces Top-Line Results of the Double-Blind Multiple Intra-Articular Injections (STRUT) Study of Ampion™ in Patients with Moderate to Severe Osteoarthritis of the Knee

Date: February 25, 2015 | READ MORE >

Ampio Pharmaceuticals to present at the International Society for Pharmaceutical Engineers (ISPE) 24th Annual Aseptic Processing Technology Conference on February 23rd, 2015

Date: February 20, 2015 | READ MORE >

Luoxis Establishes Initial European Distribution Network for RedoxSYS™ Diagnostic System

Date: January 22, 2015 | READ MORE >

Luoxis to Present at Biotech Showcase 2015

Date: January 6, 2015 | READ MORE >